84 related articles for article (PubMed ID: 25476473)
1. Induction of cytoplasmic pattern in the form of "rods and rings" through the treatment of hepatitis C: a case report.
Felisberto M; Jorge AS; Menolli RA; Gnutzmann LV; Nesi V
Rev Bras Reumatol; 2015; 55(2):181-4. PubMed ID: 25476473
[TBL] [Abstract][Full Text] [Related]
2. Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapy.
Keppeke GD; Calise SJ; Chan EK; Andrade LE
World J Gastroenterol; 2016 Feb; 22(6):1966-74. PubMed ID: 26877604
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic rods and rings autoantibodies developed during pegylated interferon and ribavirin therapy in patients with chronic hepatitis C.
Covini G; Carcamo WC; Bredi E; von Mühlen CA; Colombo M; Chan EK
Antivir Ther; 2012; 17(5):805-11. PubMed ID: 22293655
[TBL] [Abstract][Full Text] [Related]
4. Anti-rods/rings autoantibody and IMPDH filaments: an update after fifteen years of discovery.
Calise SJ; Chan EKL
Autoimmun Rev; 2020 Oct; 19(10):102643. PubMed ID: 32805424
[TBL] [Abstract][Full Text] [Related]
5. Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patients.
Novembrino C; Aghemo A; Ferraris Fusarini C; Maiavacca R; Matinato C; Lunghi G; Torresani E; Ronchi M; Garlaschi MC; Ramondetta M; Colombo M
J Viral Hepat; 2014 Dec; 21(12):944-9. PubMed ID: 25040504
[TBL] [Abstract][Full Text] [Related]
6. Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α.
Keppeke GD; Satoh M; Ferraz ML; Chan EK; Andrade LE
Immunol Res; 2014 Oct; 60(1):38-49. PubMed ID: 24845459
[TBL] [Abstract][Full Text] [Related]
7. Differential capacity of therapeutic drugs to induce Rods/Rings structures in vitro and in vivo and generation of anti-Rods/Rings autoantibodies.
Keppeke GD; Prado MS; Nunes E; Perazzio SF; Rodrigues SH; Ferraz ML; Chan EK; Andrade LE
Clin Immunol; 2016 Dec; 173():149-156. PubMed ID: 27746381
[TBL] [Abstract][Full Text] [Related]
8. Development of a recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies against "rings and rods"-associated inosine-5'-monophosphate dehydrogenase 2 in viral hepatitis C.
Probst C; Radzimski C; Blöcker IM; Teegen B; Bogdanos DP; Stöcker W; Komorowski L
Clin Chim Acta; 2013 Mar; 418():91-6. PubMed ID: 23333419
[TBL] [Abstract][Full Text] [Related]
9. Anti-rods/rings: a human model of drug-induced autoantibody generation.
Calise SJ; Keppeke GD; Andrade LE; Chan EK
Front Immunol; 2015; 6():41. PubMed ID: 25699057
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against inosine-5'-monophosphate dehydrogenase 2--characteristics and prevalence in patients with HCV-infection.
Seelig HP; Appelhans H; Bauer O; Blüthner M; Hartung K; Schranz P; Schultze D; Seelig CA; Volkmann M
Clin Lab; 2011; 57(9-10):753-65. PubMed ID: 22029192
[TBL] [Abstract][Full Text] [Related]
11. Ribavirin induces widespread accumulation of IMP dehydrogenase into rods/rings structures in multiple major mouse organs.
Keppeke GD; Calise SJ; Chan EKL; Andrade LEC
Antiviral Res; 2019 Feb; 162():130-135. PubMed ID: 30605724
[TBL] [Abstract][Full Text] [Related]
12. Clinical correlates of the "rods and rings" antinuclear antibody pattern.
Climent J; Morandeira F; Castellote J; Xiol J; Niubó J; Calatayud L; Mestre M; Bas J
Autoimmunity; 2016; 49(2):102-8. PubMed ID: 26699543
[TBL] [Abstract][Full Text] [Related]
13. A comparison of peginterferon α-2a and α-2b for treatment-naive patients with chronic hepatitis C virus: A meta-analysis of randomized trials.
Zhao S; Liu E; Chen P; Cheng D; Lu S; Yu Q; Wang Y; Wei K; Yang P
Clin Ther; 2010 Aug; 32(9):1565-77. PubMed ID: 20974315
[TBL] [Abstract][Full Text] [Related]
14. Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients.
Hsieh MY; Dai CY; Lee LP; Huang JF; Chuang WL; Hou NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Yu ML
Kaohsiung J Med Sci; 2012 Feb; 28(2):86-93. PubMed ID: 22313535
[TBL] [Abstract][Full Text] [Related]
15. Microinjection of specific anti-IMPDH2 antibodies induces disassembly of cytoplasmic rods/rings that are primarily stationary and stable structures.
Keppeke GD; Andrade LE; Grieshaber SS; Chan EK
Cell Biosci; 2015; 5(1):1. PubMed ID: 25601894
[TBL] [Abstract][Full Text] [Related]
16. [Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection].
Hunyady B; Kovács B; Battyáni Z
Orv Hetil; 2011 Dec; 152(50):1997-2009. PubMed ID: 22112373
[TBL] [Abstract][Full Text] [Related]
17. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
Carrat F; Bani-Sadr F; Pol S; Rosenthal E; Lunel-Fabiani F; Benzekri A; Morand P; Goujard C; Pialoux G; Piroth L; Salmon-Céron D; Degott C; Cacoub P; Perronne C;
JAMA; 2004 Dec; 292(23):2839-48. PubMed ID: 15598915
[TBL] [Abstract][Full Text] [Related]
18. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
Torriani FJ; Rodriguez-Torres M; Rockstroh JK; Lissen E; Gonzalez-García J; Lazzarin A; Carosi G; Sasadeusz J; Katlama C; Montaner J; Sette H; Passe S; De Pamphilis J; Duff F; Schrenk UM; Dieterich DT;
N Engl J Med; 2004 Jul; 351(5):438-50. PubMed ID: 15282351
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructure of cytoplasmic and nuclear inosine-5'-monophosphate dehydrogenase 2 "rods and rings" inclusions.
Juda P; Smigová J; Kováčik L; Bártová E; Raška I
J Histochem Cytochem; 2014 Oct; 62(10):739-50. PubMed ID: 24980853
[TBL] [Abstract][Full Text] [Related]
20. Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon alpha plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-coinfected patient.
Potthoff A; Deterding K; Trautwein C; Rifai K; Manns MP; Wedemeyer H
Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):906-9. PubMed ID: 17873617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
